Companies: 10,795·Total market cap: $144.5T
Organogenesis Holdings Inc.

Organogenesis Holdings Inc.

ORGONASDAQHealthcare● Active
$2.38
$-0.04(-1.65%)
Market Cap$306245424
P/E Ratio
52W High$7.077
52W Low$2.04
Overview

Organogenesis Holdings Inc. (ORGO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ORGO · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.15orgo eps ttm · orgo earnings per shareEarnings history
PE Ratio (TTM)orgo pe ratio ttm · orgo price to earningsPE Ratio deep dive
Revenue (TTM)$513.6Morgo revenue ttm · orgo annual revenueFull revenue history
Dividend YieldNo Dividenddoes orgo pay dividends · orgo dividend yieldDividend history
Shares Outstanding126.7Morgo shares outstanding · orgo floatShares outstanding history
Next EarningsAug 6, 2026Est.orgo earnings date · orgo next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$563.0M▲ +16.80% YoY
202320242025
organogenesis holdings inc. revenue · orgo revenue 2025
FY 2025Net Income$37.0M▲ +4201.05% YoY
202320242025
organogenesis holdings inc. net income · orgo profit 2025
FY 2025EPS$0.16▲ +2353.52% YoY
202320242025
orgo eps · organogenesis holdings inc. earnings per share 2025
TTM:Revenue: $513.6MNet Income: -$284000.00EPS: $-0.15View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis orgo a buy · orgo analyst rating
Strong Buy
0
Buy
4
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$3.00Low
$2.38Current
$3.00Avg Target26.05% upside
$3.00High
orgo price target · orgo 12 month forecast

Total: 5 · Buy rate: 80.0%

The ORGO analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing +26.05% upside from the current price of $2.38.

Stock Performance

Full History
1D-1.65%
1W+5.78%
1M+0.42%
3M-14.70%
YTD-54.05%
1Y-30.81%
5Y-84.58%

About Organogenesis Holdings Inc.

CEOGary S. Gillheeney
IPO DateJan 5, 2017
Employees869
CountryUS

Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical an…

what is organogenesis holdings inc. · orgo stock overview · organogenesis holdings inc. company profile · who is organogenesis holdings inc. ceo · orgo NASDAQ · organogenesis holdings inc. headquarters · organogenesis holdings inc. business segments

About Stock Overview & Key Data

Organogenesis Holdings Inc. (ORGO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Jan 5, 2017. As of the latest trading session, ORGO stock price is $2.38, with a market capitalization of $306.2M. The stock has returned -30.81% over the past 12 months and -54.05% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Organogenesis Holdings Inc. stock is Buy, with an average 12-month price target of $3.00. In fiscal year 2025, Organogenesis Holdings Inc. reported revenue of $563.0M and net income of $37.0M. For detailed data — including Organogenesis Holdings Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Organogenesis Holdings Inc. (ORGO) stock price is $2.38. The stock is traded on NASDAQ under the ticker symbol ORGO. The 52-week range is $2.04 – $7.08.

ORGO stock priceORGO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice